Enantioselective synthesis of (S)-suprofen ester prodrugs by lipase in cyclohexane

Enzyme and Microbial Technology

Volumn 25, Issue 8-9, 1999, Pages 682-688

  Tsai, S W ^a   Huang, C M ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

(S) suprofen ester prodrugs; Esterification; Lipase; Transesterification

Indexed keywords

ALCOHOLS; COMPOSITION EFFECTS; ENZYMES; ESTERS; HYDROCARBONS; SYNTHESIS (CHEMICAL); WATER;

CANDIDA RUGOSA; CYCLOHEXANE; LIPASE; SUPROFEN ESTER PRODRUGS;

ESTERIFICATION;

CYCLOHEXANE; ESTER DERIVATIVE; FUNGAL PROTEIN; PRODRUG; SUPROFEN; TRIACYLGLYCEROL LIPASE;

ARTICLE; CANDIDA RUGOSA; CATALYSIS; DRUG SYNTHESIS; ENANTIOMER; ENZYME ACTIVITY; ESTERIFICATION; NONHUMAN; STEREOCHEMISTRY;

CANDIDA RUGOSA;

EID: 0033230966     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-0229(99)00108-8     Document Type: Article

References (13)

1. Hutt A.J., Caldwell J. The important of stereochemistry in the clinic pharmacokinetics of the 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. Clin Pharmacokin. 9:1984;371-373.
2. Sonawane R.H., Bellur N.S., Ahuja J.R. Recent developments in the synthesis of optically active 2-arylpropionic acids an important class of nonsteroidal anti-inflammatory agents . Tetrahedron Asymmetry. 3:1992;163-192.
3. Shanbhag V.R., Crider A.M., Gokhale R., Harpalani A., Dick R.M. Ester and amide prodrugs of Ibuprofen and Naproxen synthesis, anti-inflammatory activity, and gastrointestinal toxicity . J Pharm Sci. 81:1992;149-154.
4. Bundgaard H. Design of prodrugs bioreversible derivatives for various functional groups and chemical entities . Bundgaard H. Design of prodrugs. 1985;1-92 Elsevier, Amsterdam.
5. Nielsen N.N., Bundgaard H. Glycolamide esters as biolabile prodrugs of carboxylic acid agents synthesis, stability, bioconversion, and physicochemical properties . J Pharm Sci. 77:1988;285-298.
6. Tammara V.K., Narurkar M.M., Crider A.M., Khan A.M. Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and Naproxen. Pharm Res. 10:1993;1191-1199.
7. Chang C.S., Tsai S.W. A facile enzymatic process for the preparation of (S)-Naproxen ester prodrug in organic solvents. Enzyme Microb Technol. 20:1997;635-639.
8. Tsai S.W., Lin J.J., Chang C.S., Chen J.P. Enzymatic synthesis of (S)-Ibuprofen ester prodrug from racemic Ibuprofen by lipase in organic solvents. Biotechnol Prog. 13:1997;82-88.
9. Tsai SW, Tsai CS, Chang CS. Lipase-catalyzed synthesis of (S)-Naproxen ester prodrug by transesterification in organic solvents. Appl Biochem Biotechnol Part A Enzyme Eng Biotechnol, In press.
10. Allenmark S., Ohlsson A. Enantioselectivity of lipase-catalyzed hydrolysis of some 2-chloroethyl 2-arylpropannoates studied by chiral reversed-phase liquid chromatography. Chirality. 4:1992;98-102.
11. Tsai S.W., Wei H.J. Enantioselective esterification of racemic naproxen by lipases in organic solvent. Enzyme Microb Technol. 16:1994;328-333.
12. Tsai SW, Lin SF, Chang CS. Lipase-catalyzed enantioselective esterification of S(+)-Naproxen ester prodrug in cyclohexane. J Chem Technol Biotechnol, In press.
13. Halling PJ. Thermodynamic predictions for biocatalysis in nonconventional media: theory, tests, and recommendations for experimental design and analysis. 1994;16:178-206.